Factors predicting clinically significant fatigue in women following treatment for primary breast cancer

• Published in: Supportive care in cancer Vol. 19; no. 10; pp. 1581 - 1591
• Main Authors: Gerber, Lynn H., Stout, Nicole, McGarvey, Charles, Soballe, Peter, Shieh, Ching-yi, Diao, Guoqing, Springer, Barbara A., Pfalzer, Lucinda A.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer-Verlag 01.10.2011; Springer; Springer Nature B.V
• Subjects: Adult; Age Factors; Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Body Mass Index; Breast cancer; Breast Neoplasms - physiopathology; Breast Neoplasms - therapy; Cancer; Chemotherapy; Drug therapy; Fatigue; Fatigue - epidemiology; Fatigue - etiology; Female; Follow-Up Studies; Glucose metabolism; Hemoglobin; Humans; Leukocyte Count; Leukocytes; Medicine; Medicine & Public Health; Middle Aged; Motor Activity; Nuclear radiation; Nursing; Nursing Research; Oncology; Original; Original Article; Pain Medicine; Postmenopausal women; Prospective Studies; Rehabilitation Medicine; Sleep; Function; Fatigue; Breast cancer; Rehabilitation

Cancer-related fatigue is common, complex, and distressing. It affects 70–100% of patients receiving chemotherapy and a significant number who have completed their treatments. We assessed a number of variables in women newly diagnosed with primary breast cancer (BrCa) to determine whether biological...